359 related articles for article (PubMed ID: 2507378)
1. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
[TBL] [Abstract][Full Text] [Related]
2. Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol.
Pugliese G; Tilton RG; Speedy A; Santarelli E; Eades DM; Province MA; Kilo C; Sherman WR; Williamson JR
Diabetes; 1990 Mar; 39(3):312-22. PubMed ID: 2307293
[TBL] [Abstract][Full Text] [Related]
3. Effects of islet isografts on hemodynamic and vascular filtration changes in diabetic rats.
Pugliese G; Tilton RG; Chang K; Speedy A; Province M; Eades DM; Lacy PE; Kilo C; Williamson JR
Diabetes; 1990 Mar; 39(3):323-32. PubMed ID: 2106462
[TBL] [Abstract][Full Text] [Related]
4. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration.
Williamson JR; Chang K; Tilton RG; Prater C; Jeffrey JR; Weigel C; Sherman WR; Eades DM; Kilo C
Diabetes; 1987 Jul; 36(7):813-21. PubMed ID: 3108058
[TBL] [Abstract][Full Text] [Related]
5. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
[TBL] [Abstract][Full Text] [Related]
6. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity.
Pugliese G; Tilton RG; Speedy A; Chang K; Province MA; Kilo C; Williamson JR
Metabolism; 1990 Jul; 39(7):690-7. PubMed ID: 2114513
[TBL] [Abstract][Full Text] [Related]
7. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
Bank N; Coco M; Aynedjian HS
Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
[TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Tilton RG; Chang K; Hasan KS; Smith SR; Petrash JM; Misko TP; Moore WM; Currie MG; Corbett JA; McDaniel ML
Diabetes; 1993 Feb; 42(2):221-32. PubMed ID: 7678825
[TBL] [Abstract][Full Text] [Related]
9. Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats.
Pugliese G; Tilton RG; Speedy A; Chang K; Santarelli E; Province MA; Eades D; Sherman WR; Williamson JR
Diabetologia; 1989 Dec; 32(12):845-57. PubMed ID: 2533117
[TBL] [Abstract][Full Text] [Related]
10. Effects of hypothyroidism on vascular 125I-albumin permeation and blood flow in rats.
Tilton RG; Pugliese G; Chang K; Speedy A; Province MA; Kilo C; Williamson JR
Metabolism; 1989 May; 38(5):471-8. PubMed ID: 2725286
[TBL] [Abstract][Full Text] [Related]
11. Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat.
McCaleb ML; Sredy J; Millen J; Ackerman DM; Dvornik D
J Diabet Complications; 1988; 2(1):16-8. PubMed ID: 2968349
[TBL] [Abstract][Full Text] [Related]
12. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
Goldfarb S; Simmons DA; Kern EF
Trans Assoc Am Physicians; 1986; 99():67-72. PubMed ID: 3111062
[No Abstract] [Full Text] [Related]
14. Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats.
Griffin BW; McNatt LG; Chandler ML; York BM
Metabolism; 1987 May; 36(5):486-90. PubMed ID: 3106757
[TBL] [Abstract][Full Text] [Related]
15. Increased ocular blood flow and 125I-albumin permeation in galactose-fed rats: inhibition by sorbinil.
Tilton RG; Chang K; Weigel C; Eades D; Sherman WR; Kilo C; Williamson JR
Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):861-8. PubMed ID: 3372163
[TBL] [Abstract][Full Text] [Related]
16. Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.
Körner A; Celsi G; Eklöf AC; Linné T; Persson B; Aperia A
Diabetologia; 1992 May; 35(5):414-8. PubMed ID: 1521721
[TBL] [Abstract][Full Text] [Related]
17. Aldose reductase inhibition and glomerular abnormalities in diabetic rats.
Daniels BS; Hostetter TH
Diabetes; 1989 Aug; 38(8):981-6. PubMed ID: 2502460
[TBL] [Abstract][Full Text] [Related]
18. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
Craven PA; DeRubertis FR
Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
[TBL] [Abstract][Full Text] [Related]
19. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
Sredy J; Flam BR; Sawicki DR
Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565
[TBL] [Abstract][Full Text] [Related]
20. Concurrent increases in regional hematocrit and blood flow in diabetic rats: prevention by sorbinil.
Sutera SP; Chang K; Marvel J; Williamson JR
Am J Physiol; 1992 Sep; 263(3 Pt 2):H945-50. PubMed ID: 1415621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
